Resmed Inc Stock Price Prediction
| RMD Stock | USD 233.88 1.30 0.56% |
Oversold Vs Overbought
52
Oversold | Overbought |
Quarterly Earnings Growth 0.416 | EPS Estimate Next Quarter 2.27 | EPS Estimate Current Year 7.71 | EPS Estimate Next Year 8.63 | Wall Street Target Price 253.1108 |
Using ResMed hype-based prediction, you can estimate the value of ResMed Inc from the perspective of ResMed response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in ResMed to buy its stock at a price that has no basis in reality. In that case, they are not buying ResMed because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
ResMed after-hype prediction price | USD 233.74 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
ResMed |
ResMed After-Hype Price Prediction Density Analysis
As far as predicting the price of ResMed at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in ResMed or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of ResMed, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
ResMed Estimiated After-Hype Price Volatility
In the context of predicting ResMed's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on ResMed's historical news coverage. ResMed's after-hype downside and upside margins for the prediction period are 231.98 and 235.50, respectively. We have considered ResMed's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
ResMed is very steady at this time. Analysis and calculation of next after-hype price of ResMed Inc is based on 3 months time horizon.
ResMed Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as ResMed is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ResMed backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with ResMed, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.05 | 1.76 | 0.14 | 0.01 | 11 Events / Month | 8 Events / Month | In about 11 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
233.88 | 233.74 | 0.06 |
|
ResMed Hype Timeline
On the 27th of December ResMed Inc is traded for 233.88. The entity has historical hype elasticity of -0.14, and average elasticity to hype of competition of -0.01. ResMed is expected to decline in value after the next headline, with the price expected to drop to 233.74. The average volatility of media hype impact on the company price is about 63.77%. The price depreciation on the next news is expected to be -0.06%, whereas the daily expected return is at this time at -0.05%. The volatility of related hype on ResMed is about 884.02%, with the expected price after the next announcement by competition of 233.87. About 61.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 1.77. ResMed Inc recorded earning per share (EPS) of 7.53. The entity last dividend was issued on the 7th of November 2024. The firm had 2:1 split on the 31st of August 2010. Considering the 90-day investment horizon the next expected press release will be in about 11 days. Check out ResMed Basic Forecasting Models to cross-verify your projections.ResMed Related Hype Analysis
Having access to credible news sources related to ResMed's direct competition is more important than ever and may enhance your ability to predict ResMed's future price movements. Getting to know how ResMed's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how ResMed may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| TFX | Teleflex Incorporated | (3.20) | 11 per month | 0.00 | (0.22) | 1.71 | (2.92) | 17.00 | |
| WST | West Pharmaceutical Services | 2.06 | 12 per month | 2.02 | 0.03 | 2.96 | (2.67) | 22.42 | |
| ALC | Alcon AG | (0.52) | 13 per month | 0.00 | (0.22) | 1.13 | (1.83) | 7.08 | |
| ICUI | ICU Medical | 1.21 | 10 per month | 0.00 | (0.13) | 3.24 | (2.68) | 10.44 | |
| COO | The Cooper Companies, | (0.69) | 8 per month | 0.00 | (0.26) | 1.59 | (2.14) | 6.27 | |
| BDX | Becton Dickinson and | (0.55) | 8 per month | 0.00 | (0.08) | 1.79 | (1.33) | 7.18 | |
| HOLX | Hologic | (0.78) | 10 per month | 0.00 | (0.17) | 1.69 | (1.92) | 8.14 | |
| EMBC | Embecta Corp | 0.66 | 8 per month | 2.33 | 0.11 | 4.23 | (4.50) | 32.94 | |
| BAX | Baxter International | (0.60) | 11 per month | 0.00 | (0.29) | 2.08 | (2.97) | 7.67 | |
| MMSI | Merit Medical Systems | 1.42 | 12 per month | 0.00 | (0.05) | 2.03 | (1.93) | 7.20 | |
| STAA | STAAR Surgical | (1.20) | 11 per month | 0.00 | (0.08) | 6.36 | (4.64) | 17.93 |
ResMed Additional Predictive Modules
Most predictive techniques to examine ResMed price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for ResMed using various technical indicators. When you analyze ResMed charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About ResMed Predictive Indicators
The successful prediction of ResMed stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as ResMed Inc, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of ResMed based on analysis of ResMed hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to ResMed's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to ResMed's related companies. | 2021 | 2022 | 2023 | 2024 (projected) | Dividend Yield | 0.008012 | 0.008054 | 0.0103 | 0.0138 | Price To Sales Ratio | 8.56 | 7.59 | 5.87 | 4.26 |
Story Coverage note for ResMed
The number of cover stories for ResMed depends on current market conditions and ResMed's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that ResMed is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about ResMed's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
ResMed Short Properties
ResMed's future price predictability will typically decrease when ResMed's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of ResMed Inc often depends not only on the future outlook of the potential ResMed's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ResMed's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 147.6 M | |
| Cash And Short Term Investments | 238.4 M |
Complementary Tools for ResMed Stock analysis
When running ResMed's price analysis, check to measure ResMed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ResMed is operating at the current time. Most of ResMed's value examination focuses on studying past and present price action to predict the probability of ResMed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ResMed's price. Additionally, you may evaluate how the addition of ResMed to your portfolios can decrease your overall portfolio volatility.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |